Drug Trial Radar · NCT00168662
Non-Specific Effects of Standard Titre Measles Vaccination
Last checked: Nov 20, 2026Latest source record: Feb 26, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
7,800
Actual
Start
Mar 1995
Primary completion
Jan 2006
Study completion Jan 2006
Sponsor
- Lead sponsor
- Bandim Health ProjectAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- International Cooperation with Developing Countries; Danish Council for Development Research; Medical Research Council Unit, The Gambia
- First posted
- Sep 15, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 6 months, up to 8 months
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The general objectives of the proposed research work are: A1) to reduce childhood mortality in developing countries through better control of measles infection by finding the best immunization strategy, and A2) to investigate the hypothesis that standard titre measles immunization is associated with non targeted beneficial effects on childhood morbidity and mortality in developing countries. The measurable, specific objectives of the present proposal are: B1) to examine whether a two-dose strategy for measles immunization at 6 and 9 months of age can reduce measles incidence by 50% through better coverage or improved seroconversion, and B2) to examine whether a two-dose strategy for measles immunization at 6 and 9 months of age can reduce childhood mortality by 20% through better coverage, better protection against measles or non targeted beneficial effects, and B3) to determine the magnitude and duration of non-measles related changes in morbidity patterns after standard titre measles immunization, in particular to test whether measles immunization is associated with a 15% reduction in the risk of diarrhoea, and B4) to determine non-measles related immunological changes among recipients of measles vaccine in order to establish possible pathways for the non targeted effects of standard titre measles immunization.
Conditions
- Measles
Interventions
Measles and inactivated polio vaccineBiological
Primary outcomes
What the sponsor says the trial is designed to measure.
- Vaccination coverage
- Vaccine efficacy
- Measles specific mortality
- All cause mortality until 3 years of age
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Bandim Health Project
Bissau, Apartado 861, Guinea-Bissau
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.